Almost nine in 10 patients on blockbuster weight loss drugs like Ozempic and Wegovy are quitting them early, a major review from Prime Therapeutics and Magellan Rx Management has found. Almost nine in 10 patients on blockbuster weight loss drugs like Ozempic and Wegovy are quitting them early, a major review from Prime Therapeutics and Magellan Rx Management has found.
Shocking number of people are QUITTING Ozempic amid growing list of debilitating side effects
